跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ALUNBRIG brigatinib 180 mg film-coated tablet bottle
Approved
STANDARD
ALUNBRIG brigatinib 180 mg film-coated tablet bottle
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e48c7c775a840742
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e48c7c775a840742
Product Name
ALUNBRIG brigatinib 180 mg film-coated tablet bottle
Artg Id
299967
Artg Name
ALUNBRIG brigatinib 180 mg film-coated tablet bottle
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2019-03-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/814762589ddcbbf52122fdb453cce139.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e48c7c775a840742
Type
Standard
Back to TGA Approvals
ALUNBRIG brigatinib 180 mg film-coated tablet bottle - TGA Drug Approval Details
